XML 49 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation (Tables)
6 Months Ended
Jan. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock-based Awards Outstanding by Award Type
As of January 31, 2017, the following stock-based awards, by award type, were outstanding:
Stock options
1,910,576

Performance shares
252,000

RSUs and restricted stock
308,217

Share units
7,759

Total
2,478,552

Stock-based compensation for awards detailing where recorded in Condensed Consolidated Statement of Operations
Stock-based compensation for awards issued is reflected in the following line items in our Condensed Consolidated Statements of Operations:
 
 
Three months ended January 31,
 
Six months ended January 31,
 
 
2017
 
2016
 
2017
 
2016
Cost of sales
 
$
58,000

 
100,000

 
106,000

 
163,000

Selling, general and administrative expenses
 
878,000

 
881,000

 
1,729,000

 
1,755,000

Research and development expenses
 
83,000

 
93,000

 
154,000

 
207,000

Stock-based compensation expense before income tax benefit
 
1,019,000

 
1,074,000

 
1,989,000

 
2,125,000

Estimated income tax benefit
 
(361,000
)
 
(347,000
)
 
(702,000
)
 
(712,000
)
Net stock-based compensation expense
 
$
658,000

 
727,000

 
1,287,000

 
1,413,000

Summary of net stock-based compensation expense by award type
Stock-based compensation expense, by award type, is summarized as follows:
 
 
Three months ended January 31,
 
Six months ended January 31,
 
 
2017
 
2016
 
2017
 
2016
Stock options
 
$
386,000

 
609,000

 
632,000

 
1,212,000

Performance shares
 
372,000

 
390,000

 
866,000

 
724,000

RSUs and restricted stock
 
224,000

 
35,000

 
412,000

 
106,000

ESPP
 
37,000

 
40,000

 
79,000

 
83,000

Stock-based compensation expense before income tax benefit
 
1,019,000

 
1,074,000

 
1,989,000

 
2,125,000

Estimated income tax benefit
 
(361,000
)
 
(347,000
)
 
(702,000
)
 
(712,000
)
Net stock-based compensation expense
 
$
658,000

 
727,000

 
1,287,000

 
1,413,000

Components of actual Income tax benefit recognized for tax deductions relating to settlement of stock-based awards
The following table reconciles the actual income tax benefit recognized for tax deductions relating to the settlement of stock-based awards to the excess income tax benefit reported as a cash flow from financing activities in our Condensed Consolidated Statements of Cash Flows:
 
 
Six months ended January 31,
 
 
2017
 
2016
Actual income tax benefit recorded for the tax deductions relating to the settlement of stock-based awards
 
$
335,000

 
132,000

Less: Tax benefit initially recognized on settled stock-based awards vesting subsequent to the adoption of accounting standards that require us to expense stock-based awards
 
274,000

 
127,000

Excess income tax benefit from settled equity-classified stock-based awards recorded as an increase to additional paid-in capital and reported as a cash inflow from financing activities in our Condensed Consolidated Statements of Cash Flows
 
$
61,000

 
5,000

Summary of the Plan's activity relating to stock options
The following table summarizes the Plan's activity during the six months ended January 31, 2017:
 
 
Awards
(in Shares)
 
Weighted Average
Exercise Price
 
Weighted Average
Remaining Contractual
Term (Years)
 
Aggregate
Intrinsic Value
Outstanding at July 31, 2016
 
2,256,679

 
$
28.87

 
 
 
 
Expired/canceled
 
(118,505
)
 
27.34

 
 
 
 
Outstanding at October 31, 2016
 
2,138,174

 
28.96

 
 
 
 
Expired/canceled
 
(227,598
)
 
32.06

 
 
 
 
Outstanding at January 31, 2017
 
1,910,576

 
$
28.59

 
6.01
 
$

 
 
 
 
 
 
 
 
 
Exercisable at January 31, 2017
 
1,168,372

 
$
28.57

 
5.18
 
$

 
 
 
 
 
 
 
 
 
Vested and expected to vest at January 31, 2017
 
1,850,536

 
$
28.58

 
5.97
 
$

Certain weighted average assumptions used to estimate the fair value of stock-based awards
The estimated per-share weighted average grant-date fair value of stock options granted during the three and six months ended January 31, 2016 was $3.69 and $5.69, respectively, which was determined using the Black-Scholes option pricing model, and included the following weighted average assumptions:
 
 
Three months ended
 
Six months ended
 
 
January 31, 2016
 
January 31, 2016
Expected dividend yield
 
5.74
%
 
4.32
%
Expected volatility
 
34.76
%
 
34.27
%
Risk-free interest rate
 
1.64
%
 
1.54
%
Expected life (years)
 
5.04

 
5.16


Summary of the Plan's activity relating to performance shares, RSUs, restricted stock and share units
The following table summarizes the Plan's activity relating to performance shares, RSUs, restricted stock and share units:
 
 
Awards
(in Shares)
 
Weighted Average
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Outstanding at July 31, 2016
 
217,213

 
$
28.32

 
 
Granted
 
418,684

 
13.10

 
 
Converted to common stock
 
(38,706
)
 
14.75

 
 
Forfeited
 
(5,155
)
 
25.10

 
 
Outstanding at October 31, 2016
 
592,036

 
17.80

 
 
Granted
 
2,632

 
11.40

 
 
Converted to common stock
 
(19,866
)
 
29.41

 
 
Forfeited
 
(6,826
)
 
19.65

 
 
Outstanding at January 31, 2017
 
567,976

 
$
17.34

 
$
6,094,000

 
 
 
 
 
 
 
Vested at January 31, 2017
 
35,400

 
$
26.94

 
$
380,000

 
 
 
 
 
 
 
Vested and expected to vest at January 31, 2017
 
542,282

 
$
17.34

 
$
5,819,000